KDIGO 2024 Guidelines-Key Points for Pediatricians – PubMed
KDIGO 2024 Guidelines-Key Points for Pediatricians
Related Articles
Screening for monoclonal gammopathies of undetermined significance: A prospective study – PubMed
The results of this study can be used by the Ministry of Health and the Ministry of Agriculture to provide baseline data to help develop…
Recurrent Polyuria
A 64-year-old man with a history of aplastic anemia underwent haploidentical stem cell transplantation, complicated by graft-versus-host disease affecting his gastrointestinal tract. The posttransplantation course was…
KDIGO 2024 Guidelines-Key Points for Pediatricians – PubMed
KDIGO 2024 Guidelines-Key Points for Pediatricians
GLP-1s Are Crazy Effective — Just Not Cost-Effective
We know they are expensive, but isn’t the cost recouped by the healthcare savings? Dr F. Perry Wilson explains.
Thrombotic Microangiopathy and the Kidney | Treatment & Management | Point of Care
Point of Care – Clinical decision support for Thrombotic Microangiopathy and the Kidney. Treatment and management. Introduction, Etiology, Epidemiology, Pathophysiology, Histopathology, History and Physical, Evaluation,…
Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly – PubMed
Discovering the brakes/checkpoints that cancer places on the immune system to prevent being eradicated led to the 2018 Nobel Prize and the development of multiple…
Diabetic Kidney Disease – PubMed
Diabetic kidney disease is a leading cause of kidney failure worldwide and is easily detectable with screening examination. Diabetes causes hyperfiltration and activation of the…
Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke
This phase 2, response-adaptive randomized clinical trial compares 4 separate times to initiate treatment with a direct oral anticoagulant after atrial fibrillation (AF)–related stroke on…
Medium- and Distal-Vessel Occlusion — The Limit of Thrombectomy? | NEJM
Few procedures have gone through a decade of practice-changing clinical trials as impressive as thrombectomy for stroke. Beginning in 2015 with multiple trials showing a…
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours | NEJM
The effects and risks of the use of intravenous thrombolysis between 4.5 and 24 hours after the onset of a posterior circulation ischemic stroke are…